Investigations
ADMA Biologics, Inc.
Overview
Overview
- Deadline:
- Upcoming
| Company Name: | Company Name: ADMA Biologics, Inc. |
| Stock Symbol: | Stock Symbol: ADMA |
ADMA Biologics, Inc. (NASDAQ: ADMA): ADMA is being investigated for violations of the federal securities laws in connection with potential false and misleading statements made to investors and a subsequent significant price decline in the stock.
If you incurred losses on your investments in ADMA, you are encouraged to submit your information.
Why is ADMA being Investigated?
On October 9, 2024, ADMA disclosed the surprise resignation of its independent outside auditor CohnReznick LLP.
The Stock Declines as the Truth is Revealed
The news has caused a precipitous decline in the price of ADMA stock. During trading on October 10, 2024, the price of ADMA stock declined more than 20%.
What are my Rights?
If you incurred losses on your investments in ADMA, you are encouraged to submit your information to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
If you incurred losses on your investments in ADMA, you are encouraged to submit your information.
Why is ADMA being Investigated?
On October 9, 2024, ADMA disclosed the surprise resignation of its independent outside auditor CohnReznick LLP.
The Stock Declines as the Truth is Revealed
The news has caused a precipitous decline in the price of ADMA stock. During trading on October 10, 2024, the price of ADMA stock declined more than 20%.
What are my Rights?
If you incurred losses on your investments in ADMA, you are encouraged to submit your information to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619
All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.